Optimizing Ketamine Infusion Prior Authorization for Orthopedics

The Role of Ketamine Infusion in Orthopedic Pain Management

Ketamine Infusion is increasingly utilized in orthopedic settings for managing severe, chronic, and neuropathic pain conditions, including Complex Regional Pain Syndrome (CRPS) and intractable post-surgical pain that has not responded to conventional therapies. Its application extends to patients who have undergone extensive orthopedic interventions or suffer from conditions like phantom limb pain. Securing prior authorization is a critical step for patient access.

Prior Authorization Challenges for Ketamine Infusion in Orthopedics

While orthopedic prior authorization commonly focuses on advanced imaging and surgical procedures, Ketamine Infusion presents unique challenges centered on medical necessity and failed conservative care. Payers often require extensive documentation demonstrating the patient's specific diagnosis, the chronicity and severity of pain, and a comprehensive history of failed traditional pain management interventions, aligning with the stringent review common in orthopedic PAs.

Essential Documentation for Ketamine Infusion Prior Authorization

• Detailed diagnosis of chronic or neuropathic pain condition (e.g., CRPS, intractable post-surgical pain) with correlation to orthopedic history.
• Comprehensive history of failed conservative therapies, including physical therapy, pharmacotherapy (NSAIDs, opioids, neuropathic agents), and interventional pain procedures, documenting duration and response.
• Objective pain scores and functional limitation assessments, demonstrating severity and impact on daily activities.
• Psychological evaluation and clearance, especially for long-term or repeated infusions, to rule out contraindications.
• Documentation of prior imaging (MRI, CT) to confirm underlying orthopedic pathology and rule out other causes of pain, where applicable.
• Treatment plan outlining infusion frequency, dosage, and expected functional outcomes.

Navigating Common Denial Patterns for Ketamine Infusion in Orthopedic Practices

• **Insufficient conservative-care trial**: Lack of documented duration or variety of failed prior treatments, mirroring common orthopedic denials for surgical interventions.
• **Lack of medical necessity**: Payer deems the condition not severe enough or Ketamine not the most appropriate next step based on policy, often due to missing clinical evidence.
• **Inadequate documentation of diagnosis**: Insufficient detail linking the pain condition directly to the need for Ketamine, or poor correlation with orthopedic findings.
• **Off-label use**: Payer policy may not cover Ketamine for specific orthopedic pain indications without robust evidence or specific guidelines.
• **Missing psychological evaluation**: Required by many payers to assess patient suitability and safety for infusion therapy.
• **Site-of-service mismatch**: Infusion planned for an outpatient facility when payer policy directs to a different setting or specific hospital tier.

Klivira's Solution for Orthopedic Ketamine Infusion PA

Klivira streamlines the prior authorization process for Ketamine Infusion in orthopedic settings by leveraging intelligent automation. Our platform integrates with your EMR to extract critical data points, including conservative care history, pain scores, and diagnostic imaging results, which are then mapped to payer-specific medical necessity criteria. This reduces manual effort, accelerates submission, and minimizes denial rates for complex pain management therapies, allowing orthopedic practices to focus on patient care.